Threat intelligence · CVE-2022-31049
Vulnerabilities in TYPO3 Multiple vulnerabilities have been identified in TYPO3 (web content management system written in PHP), leading to XSS and security bypass atta…
Published Jun 28, 2022 · the affected product
Last checked Nov 4, 2026. A connected source was read within the last 7 days.
Check if you run it
No confirmed exploitation is on record for CVE-2022-31049. EPSS is 0.78%. Act only if a listed version of the affected product is installed.
Gaps on this record
- No plain product name is stored. The page cannot tell you which product to check.
- No vendor fix or required action is stored. Compare the linked advisory before you change production.
- Severity
- Unknown—
- Known exploitation
- Not in CISA/VulnCheck KEV
- EPSS
- 0.78%
- Remediation
- Version ranges on file
- Affected products
- cpe typo3/typo3
Vulnerabilities in TYPO3 Multiple vulnerabilities have been identified in TYPO3 (web content management system written in PHP), leading to XSS and security bypass attacks. How it can be Exploited CVE-2022-31050: The security bypass vulnerability exists in Typo3 because due to an insufficient session expiration issue. CVE-2022-31049: The cross-site scripting vulnerability exists in Typo3 due to improper validation of
Are you affected?
Enter the version you run. The result uses only the ranges stored on this record.
The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.
- cpe typo3/typo3< 10.4.29
- cpe typo3/typo3< 11.5.11
- cpe typo3/typo3< 9.5.35
How to fix CVE-2022-31049
Upgrade
CVE-2022-31049 lists a fix boundary at 10.4.29. Compare the installed build with that boundary before you change production.
Version check
Affected < 10.4.29
Advisory
Open the cve_org record and follow its fix.
Official advisories
What to do
Three questions, each answered from this record only. Confirm the vendor advisory before you patch.
Should you patch?
No confirmed exploitation is on record for CVE-2022-31049. EPSS is 0.78%. Act only if a listed version of the affected product is installed.
Which versions are affected?
Compare what you have installed with < 10.4.29, < 11.5.11, < 9.5.35. Compare the installed version with the linked vendor advisory before you change production.
What should an analyst verify?
CWE-79: Cross-site Scripting (XSS). EPSS 0.78%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.
Technology hubs
Code
The project this record applies to. Exploit listings stay in References.
Timeline
Detection, updates, and resolution for this record.
Jun 28, 2022 · AlienVault OTX
Detected
Vulnerabilities in TYPO3 Multiple vulnerabilities have been identified in TYPO3 (web content management system written in PHP), leading to XSS and security bypass attacks. How it can be Exploited CVE-2022-31050: The security bypass vulnerability exists in Typo3 because due to an insufficient session expiration issue. CVE-2022-31049: The cross-site scripting vulnerability exists in Typo3 due to imp
Sources
- CVE.orgVulnerability recordCVE-2022-31049
Official CVE identifier
cve.org - FIRST EPSSExploitation probabilityCVE-2022-31049
30-day exploitation probability 0.78%
first.org - Monitored products — highVendor advisoryCVE-2022-31049
TYPO3 is an open source web content management system. Prior to versions 9.5.34 ELTS, 10.4.29, and 11.5.11, user submitted content was used without being properly encoded in HTML emails sent to users. The actually affected components were mail clients used to view those messages. TYPO3 versions 9.5.34 ELTS, 10.4.29, and 11.5.11 contain a fix for the problem.
nvd.nist.gov - AlienVault OTXThreat intelligenceCVE-2022-31049otx.alienvault.com
References
Freshness
Last verified in this catalog Nov 3, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.
- CVE.orgNov 4, 2026
- Monitored products — highNov 4, 2026
- FIRST EPSSNov 3, 2026
- AlienVault OTXNov 2, 2026